文献速递妇科

机器人辅助与传统腹腔镜手术治疗子宫内膜癌:一项随机对照试验的长期结果

Robotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2024-08-23

该随机对照试验在芬兰坦佩雷大学医院妇科与产科开展,2010至2013年间将101例低级别子宫内膜癌患者术前1:1随机分配至机器人辅助或传统腹腔镜组,97例随访至少10年。多变量回归分析显示机器人辅助组总生存更优(HR 0.39,95%CI 0.15-0.99,P=.047),无进展生存无差异(log-rank P=.598),但机器人辅助组穿刺孔疝发生率更高(18.2% vs 4.1%,OR 5.42,95%CI 1.11-26.59,P=.028)。

要点

  • 机器人辅助组总生存优于传统腹腔镜组(HR 0.39,95%CI 0.15-0.99,P=.047)。
  • 两组无进展生存无差异(log-rank检验P=.598)。
  • 机器人辅助组穿刺孔疝发生率18.2%,传统腹腔镜组4.1%(OR 5.42,P=.028)。

核心结论

  • 该随机对照试验结果提示,与传统腹腔镜相比,机器人辅助腹腔镜术后子宫内膜癌总生存有轻度获益。
  • 机器人辅助技术在子宫内膜癌治疗中似乎安全,但需更大规模随机对照试验确认潜在的生存获益。
  • 机器人辅助组未检测到令人担忧的安全信号,长期并发症发生率仅在穿刺孔疝发生率上存在差异。

研究设计与样本

  • 该随机对照试验在芬兰坦佩雷大学医院妇科与产科开展。
  • 2010至2013年间,101例拟行微创手术的低级别子宫内膜癌患者术前1:1随机分配至机器人辅助或传统腹腔镜组。
  • 所有患者行腹腔镜子宫切除术、双侧输卵管卵巢切除术及盆腔淋巴结切除术。
  • 共97例(机器人辅助组49例,传统腹腔镜组48例)随访至少10年。
  • 采用Kaplan-Meier曲线、log-rank检验和Cox比例风险模型分析生存,二元logistic回归分析穿刺孔疝危险因素。

主要发现

  • 多变量回归分析中,机器人辅助组总生存优于传统腹腔镜组(HR 0.39,95%CI 0.15-0.99,P=.047)。
  • 无进展生存无差异(log-rank检验P=.598)。
  • 传统腹腔镜组与机器人辅助组的3年总生存分别为98.0%(95%CI 94.0-100)与97.9%(93.8-100)。
  • 传统腹腔镜组与机器人辅助组的5年总生存分别为91.8%(95%CI 84.2-99.4)与93.7%(86.8-100)。
  • 传统腹腔镜组与机器人辅助组的10年总生存分别为75.5%(95%CI 64.5-87.5)与85.4%(75.4-95.4)。

临床怎么用

  • 作者认为,机器人辅助技术用于子宫内膜癌治疗似乎安全,但需更大规模随机对照试验确认潜在的生存获益。

局限性

  • 原文指出,机器人辅助腹腔镜术后长期肿瘤学结局的数据稀缺,且仅基于回顾性队列研究。
  • 原文结论指出,需更大规模随机对照试验确认任何潜在的生存获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic-assisted laparoscopy has become a widely and increasingly used modality of minimally invasive surgery in the treatment of endometrial cancer. Due to its technical advantages, robotic-assisted laparoscopic surgery offers benefits, such as a lower rate of conversions compared to conventional laparoscopy. Yet, data on long-term oncological outcomes after robotic-assisted laparoscopy is scarce and based on retrospective cohort studies only. OBJECTIVE: This study aimed to assess overall survival, progression-free survival, and long-term surgical complications in patients with endometrial cancer randomly assigned to robotic-assisted or conventional laparoscopy. STUDY DESIGN: This randomized controlled trial was conducted at the Department of Gynecology and Obstetrics of Tampere University Hospital, Finland. Between 2010 and 2013, 101 patients with low-grade endometrial cancer scheduled for minimally invasive surgery were randomized preoperatively 1:1 either to robotic-assisted or conventional laparoscopy. All patients underwent laparoscopic hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy. A total of 97 patients (49 in the robotic-assisted laparoscopy group and 48 in the conventional laparoscopy group) were followed up for a minimum of 10 years. Survival was analyzed using Kaplan-Meier curves, log-rank test, and Cox proportional hazard models. Binary logistic regression analysis was used to analyze risk factors for trocar site hernia. RESULTS: In the multivariable regression analysis, overall survival was favorable in the robotic-assisted group (hazard ratio 0.39; 95% confidence interval [CI], 0.15-0.99, P=.047) compared to the conventional laparoscopy group. There was no difference in progression-free survival (log-rank test, P=.598). The 3-, 5-, and 10-year overall survival were 98.0% (95% CI, 94.0-100) vs 97.9% (93.8-100), 91.8% (84.2-99.4) vs 93.7% (86.8-100), and 75.5% (64.5-87.5) vs 85.4% (75.4-95.4) for the conventional laparoscopy and the robotic-assisted groups, respectively. Trocar site hernia developed more often for the robotic-assisted group compared to the conventional laparoscopy group 18.2% vs 4.1% (odds ratio 5.42, 95% CI, 1.11-26.59, P=.028). The incidence of lymphocele, lymphedema, or other long-term complications did not differ between the groups. CONCLUSION: The results of this randomized controlled trial suggest a minor overall survival benefit in endometrial cancer after robotic-assisted laparoscopy compared to conventional laparoscopy. Hence, the use of robotic-assisted technique in the treatment of endometrial cancer seems safe, though larger randomized controlled trials are needed to confirm any potential survival benefit. No alarming safety signals were detected in the robotic-assisted group since the rate of long-term complications differed only in the incidence of trocar site hernia.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kivekäs E, Staff S, Huhtala HSA, et al. Robotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial. Am J Obstet Gynecol. 2024. PMID: 39181495. doi:10.1016/j.ajog.2024.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。